TIK-101 (dCS) - NMDA partial agonist with initial indication targets in anxiety disorders, and a potential to cause a paradigm shift in the approach to psychotherapy.
TIK-201(NaPB) - HDAC inhibitor whose initial indication is Spinal Muscular Atrophy with label expansions to ALS and MS. |